Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
108M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
21M
-
Shares change
-
+2.32M
-
Total reported value, excl. options
-
$12M
-
Value change
-
+$1.32M
-
Number of buys
-
11
-
Number of sells
-
-11
-
Price
-
$0.57
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q1 2025
31 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q1 2025.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21M shares
of 108M outstanding shares and own 19.53% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (10.2M shares), ARMISTICE CAPITAL, LLC (8.21M shares), GEODE CAPITAL MANAGEMENT, LLC (762K shares), VANGUARD GROUP INC (706K shares), BlackRock, Inc. (445K shares), STATE STREET CORP (148K shares), Silverberg Bernstein Capital Management LLC (141K shares), NORTHERN TRUST CORP (118K shares), UBS Group AG (83.2K shares), and Squarepoint Ops LLC (60.8K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.